To this end, we differentiated moderate to severe SMA patient-specific iPSCs into NGN2 cortical glutamatergic neurons, exposed each line to a novel library of 360 neuroactive CNS disease-related perturbagens, and measured transcriptional changes in a curated set of 467 neural genes. The gene discussed is NEUROG2; the disease is proximal spinal muscular atrophy.